Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001544227-21-000013

Options or other derivatives

  • Executive Chair acquired 24,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Owens Julia C. Executive Chair 2021-03-17 Grant or award · Stock Option (right to buy) +24,000 24,000 D
Loading xslF345X03/wf-form4_161618685991338.xml…